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Introduction: Primary lymphoma of the liver is an extremely rare finding, with the few such cases reported in the
literature to date describing indeterminate imaging findings, being focused more on computed tomography. To
the best of our knowledge, there is no prior report describing magnetic resonance imaging scan findings with such
a lesion. In the case reported here, magnetic resonance imaging gave us the opportunity to ascertain the correct
diagnosis, confirmed by histopathology, thus avoiding unnecessary surgery or other treatments. Although this
condition is rare, knowledge of magnetic resonance imaging findings will be invaluable for radiologists and other
medical subspecialties that may face such cases in the future in helping to provide adequate management for
affected patients.
Case presentation: A focal lesion was incidentally detected by ultrasound in a 75-year-old asymptomatic Albanian
man being treated for benign hypertrophy of prostate. Chest and abdomen computed tomography scans did not
reveal any abnormal findings besides a solid focal lesion on the right lobe of the liver and a mild homogenous
enlargement of the prostate gland. Subsequently, magnetic resonance imaging of the upper abdomen was
performed for better characterization of this lesion. Our patient was free of symptoms and his laboratory test results
were normal.
Conclusions: The magnetic resonance imaging scan results showed some distinctive features that helped us to
make the correct diagnosis, and were thus very important in helping us provide the correct treatment for our
patient.Introduction
Primary lymphoma of the liver is extremely rare. There
are few prior cases describing the imaging findings of
such lesions. Most of these articles to date are based on
computed tomography (CT) findings, and to the best of
our knowledge there are no articles describing magnetic
resonance imaging (MRI) findings in any detail [1-3]. In
this case we present imaging, clinical and laboratory
findings, and a review of the literature. Our patient was
free of symptoms and no further treatment was recom-
mended. The lesion was unchanged based on the follow-
up MRI scans performed every six months for the next
two years.* Correspondence: fatmirb_1999@yahoo.com
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We report the MRI findings of an incidental focal liver
lesion, which was detected by ultrasound (US) in a 75-
year-old Albanian man treated for benign hypertrophy
of the prostate. His physical examination and laboratory
test results were unremarkable.
Multi-detector chest and abdominal computed tomog-
raphy (MDCT), with intravenous administration of
100mL iodinated contrast material was performed using
a Emotion 6 MDCT device (Siemens Medical Systems,
Erlangen, Germany). MDCT scans showed a focal liver
lesion in the right lobe, and a mild enlargement of the
prostate gland. No other abnormalities were identified in
the rest of his chest and abdomen. Subsequently, an
MRI scan of the upper abdomen was performed for bet-
ter characterization of this lesion.
An MRI scan was performed using a 1.5T magnetic res-
onance unit (Avanto; Siemens Medical Systems, Erlangen,
Germany), using a set protocol including unenhanced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Photograph of the pathology specimen. The figure
shows a histopathology section of the liver obtained through
ultrasound (US)-guided biopsy, showing the lymphoid tissue
infiltrating the liver parenchyma. The lymphoid tissue is composed
of small lymphocytes with oval and irregular nuclei and clear
cytoplasm (hematoxylin and eosin stain, ×40).
Figure 3 Axial T2-weighted with fat suppression magnetic
resonance imaging (MRI) scan showing a mass that
demonstrates moderate homogenous hyperintensity, but that
is iso-intense when compared with spleen parenchyma.
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phase at 25 seconds after administration of intravenous
contrast gadolinium (Magnevist, Bayer HealthCare) at
2mL/second, 45 and 90 seconds (late phase).
Two-dimensional gradient echo in axial plane was per-
formed using these parameters: TR/TE 140 to 200/2.2 to
2.4ms, flip angle 80, slice thickness 6mm, image matrix
128 × 256 and acquisition time 20 seconds.
A three-dimensional gradient echo sequence (VIBE)
with a fat saturation was performed before and afterFigure 2 Axial in-phase gradient echo (GRE) T1-weighted
magnetic resonance imaging (MRI) scan, obtained as a part of
dual GRE (chemical shift) sequences, showing a focal mass in
the right lobe to be hypointense when compared to liver
parenchyma, but iso-intense compared to spleen parenchyma.administration of intravenous contrast using the follow-
ing parameters: 5.58/2.38ms, flip angle 10, matrix
320 × 256, slice thickness 3.3mm and acquisition time 20
seconds.
A dual T1-weighted spoiled gradient echo (SGE)
sequences in phase/out-of-phase was obtained in the axial
plane using the following parameters: 113/4.92/2.22ms,
flip angle 70, slice thickness 8mm and acquisition time 22
seconds for each sequence.
T2-weighted half-Fourier acquisition single-shot turbo
spin echo (HASTE) with and without fat saturation was
obtained using the following parameters: 1000/94ms, flip
angle 15, slice thickness 6mm, matrix 320× 246 and ac-
quisition time 22 seconds.Figure 4 Axial three-dimensional arterial phase gradient echo
(GRE) T1-weighted images demonstrating mild homogeneous
enhancement of the mass.
Figure 5 Axial three-dimensional late phase gradient echo
(GRE) T1-weighted images, obtained 90 seconds after
administration of intravenous contrast, demonstrating
perilesional enhancement of the mass.
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To make a diagnosis of primary lymphoma of the liver
by imaging is a challenging task because of the rarity of
such lesions and indeterminate imaging findings of the
same published to date [1]. The differential diagnosis
includes a broad range of solitary solid lesions.
The primary concern is hepatocellular carcinoma
(HCC). HCC develops in 80% of cases in the cirrhotic
liver, mainly in patients who test positive for hepatitis B
or C, in alcoholic cirrhosis or in a combined form; it is
less likely in other cases with primary biliary cirrhosis,
hemochromatosis, or cryptogenic cirrhosis.
Our patient was free of symptoms: his laboratory test
results did not suggest liver damage.
His α-fetoprotein (AFP) level was within the normal
range; our patient was not alcoholic, and he tested nega-
tive for hepatitis B and C.
His MRI scan results did not show morphologic changes
favoring cirrhosis. Even in the absence of risk factors, HCC
of this size is usually a hyper-vascular tumor that shows
marked homogeneous enhancement in the arterial phase
with late washout that is presented with capsular enhance-
ment [2]. The appearance of the lesion on MRI scan was
different, so HCC was excluded.
Liver metastasis was the next concern for our patient.
However, our patient did not have any known history of
a primary tumor. Additionally, all test results for tumor
markers were negative.
The MRI appearance of metastases is variable in T1-
weighted and T2-weighted images, but metastases usu-
ally possess a ring enhancement in the delayed phase
after administration of intravenous contrast [3]. Due to
the lack of this type of enhancement with no primarytumor history and with all tumor markers testing nega-
tive, this made metastasis unlikely as well.
Secondary liver involvement by lymphoma is common.
Such lesions are usually multiple and resemble metastases.
It is often associated with spleen involvement and
enlarged lymph nodes along the lymphatic chain of the
abdomen and mesentery. The appearance on CT and MRI
is variable, and does not reveal any signs typical for liver
infiltration by lymphoma. Knowing the history of lymph-
oma is pivotal to making the right characterization [4].
Our patient’s chest and abdominal CT scans did not
show any enlarged lymph nodes, and our patient did not
have any history of prior known lymphoma. The liver le-
sion was solitary and did not look like a metastasis. In
this setting secondary lymphoma of the liver was entirely
excluded.
A mesenchymal lesion, representing as a focal mass,
should be the other major differential diagnosis, espe-
cially inflammatory myofibroblastic tumor and unusual
mesenchymal tumor.
The MRI appearance of inflammatory myofibroblastic
tumor is equivocal and is often accompanied by soft tissue
infiltrating the periportal space. Characterization of these
lesions even with MRI is difficult. When they are suspected,
a biopsy is needed to make a definitive diagnosis [5].
Mesenchymal tumors of the liver are very rare, and
their appearance is similar to malignant epithelial tumor.
Some of them possess distinctive features that may help
to suggest the correct diagnosis, but in most cases, the
definitive diagnosis is made through histopathological
examination [6].
Our patient underwent ultrasound-guided biopsy, and
pathology revealed a low-grade B cell lymphoma. The
pathology specimen showed marginal infiltration by B
cells, which on testing were immunohistochemically
positive for CD20 and negative for CD10, CD3, CD43
and B cell lymphoma 2 proteins (Bcl-2) (Figure 1).
The rest of our patient’s chest and abdominal CT results
did not show any nodal involvement, or any other organ
infiltration. His laboratory test results were within normal
ranges.
Primary lymphoma of the liver is defined as a disease
where the involvement is confined to the liver or portal
hepatic lymph nodes, without involvement of the spleen,
other lymph nodes or bone marrow. It accounts for less
than 1% of extranodal lymphomas. The causes are not well
known, and there is no wide consensus on treatment [7]. It
usually affects patients in the seventh to eighth decade of
life and is more common in men, with a male to female
ratio of 4:1.
It is located more often in the right lobe that in the left
lobe. There is an increasing incidence of cases in patients
who are immunocompromised. Even the pathological fea-
tures are very variable and additional clinical findings are
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ally complain of right flank pain, anorexia, and diaphoresis
or weight loss. Our patient was free of symptoms and no
further treatment was recommended.
The lesion was followed-up for a two-year period, with
MRI scans performed every six months for up to two
years; in that time the lesion remained unchanged.
There are a few radiological reports describing the im-
aging findings of primary lymphoma of the liver. CT scans
usually show a large hypodense lesion, which shows mild
enhancement after administration of intravenous contrast.
The lesions can be solitary or multiple and only in one pre-
vious case showed a marked enhancement. Some lesions
contain an area of necrosis or calcification [9].
MRI, because of its superior soft tissue discrimination,
gives more information about the internal structure of
these lesions and mode of enhancement. On MRI, these
lesions are usually low signal in T1, moderately high sig-
nal in T2, demonstrating mild enhancement with target
appearance in the one hour late phase, composed of a
central enhancement portion surrounded by a hypoin-
tense rim. This is a unique feature, different from malig-
nant tumors arising from hepatocytes [10].
In our patient’s case, we observed some distinctive fea-
tures that helped us to make the correct diagnosis. The
lesion was iso-intense with spleen parenchyma on both
T1-weighted and T2-weighted images in spite of signal
intensity compared with liver parenchyma (Figures 2, 3).
It showed mild homogenous enhancement in the arterial
phase and some mild perilesional enhancement in the
delayed phase obtained 90 seconds after administration
of intravenous contrast (Figures 4, 5).Conclusions
This case illustrates the MRI findings of primary lymph-
oma of the liver. MRI provides some distinctive features,
such as iso-intensity with spleen parenchyma in both
T1-weighted and T2-weighted images and mild perile-
sional enhancement in delayed images. Although these
cases are very rare, knowledge of these imaging findings
will be helpful for radiologists to suggest the correct
diagnosis and other medical subspecialties to provide ad-
equate treatment.Consent
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